J3 Bioscience, Inc.

J3 Bioscience is a women's health innovator developing the LIV-Ring®, a patented intravaginal delivery platform designed for sustained, localized, and systemic delivery of active and functional ingredients. The LIV-Ring is a next-generation intravaginal ring (IVR) system engineered to provide continuous, controlled release of therapeutic compounds over periods ranging from days to multiple months. Inserted discreetly within the vaginal canal, the device offers women a long-acting, science-backed alternative to conventional oral therapies, enabling better bioavailability, reduced side effects, and freedom from daily dosing. The platform is currently being evaluated for indications including vaginal dryness relief and cancer-therapy-related vaginal dryness. J3 is focused on rethinking how therapies are delivered for women by working with female biology rather than against it.